Salt Intake and Kidney Outcomes in Older Adults With Chronic Kidney Disease: A Stage‐Specific Cohort Study
Nephrology · 2026
DOI: 10.1111/nep.70285 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Nephrology, 2026. Verfasst von Hiroaki Miyauchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Glomerular Filtration Rate, Sodium Chloride, Dietary, Kidney. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Aim
In patients with chronic kidney disease (CKD), salt restriction has been shown to lower blood pressure and proteinuria and to provide kidney protective effects. However, the benefit of salt restriction in older adults with CKD remains unclear, particularly in advanced stages.
Methods
We conducted a single‐center retrospective cohort study of patients aged ≥ 75 years with CKD (estimated glomerular filtration rate [eGFR] < 60 mL/min/1.73 m 2 ). Salt intake was estimated from spot urine using the Tanaka formula and categorized into quartiles. The primary outcome was a composite kidney endpoint of ≥ 30% eGFR decline or initiation of kidney replacement therapy. Cox proportional hazards models and competing risk analyses were performed, stratified by CKD stage.
Results
A total of 462 patients (median age, 79 years; 68.6% male) were included. Of these, 305 had CKD Stage 3 and 157 had Stages 4–5. During a median follow‐up of 2.79 years, 121 patients (26.2%) experienced the composite outcome. In Stage 3 CKD, higher salt intake was significantly associated with increased risk (adjusted HR 2.70; 95% CI 1.02–7.12; highest vs. lowest quartile), and findings were consistent across sensitivity analyses. In contrast, no significant association was observed in Stages 4–5.
Conclusion
Among older adults with CKD, excessive salt intake was associated with adverse kidney outcomes in CKD Stage 3 but not in Stages 4–5. These results suggest that salt restriction may be most beneficial in the early stages of CKD in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Endocrinology, and Metabolism, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
- Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan.
ORCID-Profile: Hiroaki Miyauchi, Tatsuhiko Azegami, Takashin Nakayama, Hirotaka Shibata, Kaori Hayashi
Zitieren
APA
Miyauchi, H., Azegami, T., Nakayama, T., Mitsue, C., Shibata, H., & Hayashi, K. (2026). Salt Intake and Kidney Outcomes in Older Adults With Chronic Kidney Disease: A Stage‐Specific Cohort Study. Nephrology. https://doi.org/10.1111/nep.70285
Vancouver
Miyauchi H, Azegami T, Nakayama T, Mitsue C, Shibata H, Hayashi K. Salt Intake and Kidney Outcomes in Older Adults With Chronic Kidney Disease: A Stage‐Specific Cohort Study. Nephrology. 2026. doi:10.1111/nep.70285
BibTeX
@article{Miyauchi2026,
author = {Miyauchi, Hiroaki and Azegami, Tatsuhiko and Nakayama, Takashin and Mitsue, Chisato and Shibata, Hirotaka and Hayashi, Kaori},
title = {Salt Intake and Kidney Outcomes in Older Adults With Chronic Kidney Disease: A Stage‐Specific Cohort Study},
journal = {Nephrology},
year = {2026},
doi = {10.1111/nep.70285}
}
EUVIMED